BioSpace News Archive

Evotec SE announced that, as part of its ongoing collaboration with STORM Therapeutics, the leading biotechnology company focused on the discovery and development of small molecule therapies modulating RNA epigenetics, STORM has selected STC-15 as a first-in-class development candidate.

AlzeCure has had another productive quarter during which its operations progressed according to plan, with advances in all three of our project platforms: NeuroRestore, Alzstatin and Painless.

Collaboration with world-renowned research centre to accelerate development of exosome therapies for rare diseases

Genesis Innovation Group’s cultivate Capital Fund II LP announces that one of their portfolio companies, Tucson-based SafKan Health, a medical device company that has developed the first automated ear cleaning device, the OtoSetTM Ear Cleaning System has received its 510 clearance from the US Food and Drug Administration.

Large randomized, sham-controlled trial evaluates interatrial shunting in a heart failure population currently without effective treatment

Theravance Biopharma, Inc., a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines

Kurin Inc., the inventor and manufacturer of 510-cleared Kurin® blood culture collection sets, announced that the United States Patent Office allowed its patent application and has issued U.S. Patent No. 10,827,964.

Triplet Therapeutics, Inc., a biotechnology company leveraging insights from the human genetics of repeat expansion disorders, announced the appointments of Kathy Biberstein, J.D., and Stephen Webster to its board of directors.

Customers can now purchase prescription medications through the Amazon online store – convenient and reliable access, without leaving home

Spatial Analysis of up to 30 Proteins on FFPE Tumor Biopsies May Inform Patient Treatment Decisions